← Back to Search

Dynamic PET/CT Imaging for Stroke

N/A
Waitlist Available
Led By Richard L Wahl, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Scheduled to undergo a clinical PET/CT scan with any clinically prescribed radiotracer for known or suspected malignancy (pathologic confirmation not required)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 and approximately 1 week later
Awards & highlights

Study Summary

This trial is comparing images from the first hour after a stroke to routine images to see if they are different.

Who is the study for?
This trial is for adults over 18 who can give informed consent and are scheduled for a PET/CT scan with any radiotracer due to suspected or confirmed cancer. It's not necessary to have pathologic confirmation of the malignancy.Check my eligibility
What is being tested?
The study aims to compare images taken during the first hour of dynamic PET/CT imaging with routine clinical scan images, in patients undergoing scans for known or suspected cancer.See study design
What are the potential side effects?
Since this trial involves standard imaging procedures, side effects may include discomfort from lying still during the scan and potential reactions to contrast agents used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am scheduled for a PET/CT scan for a suspected or confirmed cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 and approximately 1 week later
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 and approximately 1 week later for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of Rapid, Whole-body Dynamic PET Imaging as Measured by Number of Participants Who Successfully Completed the Study Imaging Component
Secondary outcome measures
Clinical Impacts of Data Motion Correction (OncoFreeze) as Measured by Mean Relative Lesion Number Between Belt-gating Optimal Gate and Elastic Motion Correction With Blurring Utilizing Belt Gating
Clinical Impacts of Data Motion Correction (OncoFreeze) as Measured by Mean Relative Lesion Number Between Belt-gating Optimal Gate and Elastic Motion Correction With Blurring Utilizing Data-driven Gating
Clinical Impacts of Data Motion Correction (OncoFreeze) as Measured by Mean Relative Lesion Number Between Elastic Motion Correction With Blurring Utilizing Belt Gating and Elastic Motion Correction With Blurring Utilizing Data-driven Gating
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dynamic PET ImagingExperimental Treatment1 Intervention
Dynamic PET/CT imaging will begin at approximately the same time as the clinically prescribed radiotracer injection and will continue until approximately the start of the clinical scan A subset of patients (up to 30 scheduled to undergo FDG or DOTATATE PET/CT imaging) will be asked to return within 7 days for a repeat imaging study.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,944 Previous Clinical Trials
2,304,413 Total Patients Enrolled
Siemens Corporation, Corporate TechnologyIndustry Sponsor
21 Previous Clinical Trials
9,316 Total Patients Enrolled
Richard L Wahl, M.D.Principal InvestigatorWashington University School of Medicine
3 Previous Clinical Trials
53 Total Patients Enrolled

Media Library

Dynamic PET/CT Imaging Clinical Trial Eligibility Overview. Trial Name: NCT04283552 — N/A
Dynamic PET/CT Imaging Research Study Groups: Dynamic PET Imaging
Dynamic PET/CT Imaging Clinical Trial 2023: Dynamic PET/CT Imaging Highlights & Side Effects. Trial Name: NCT04283552 — N/A
Dynamic PET/CT Imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT04283552 — N/A
~16 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top